The epidemiology of human Taenia solium infections: a systematic review of the distribution in Eastern and Southern Africa

Gideon Zulu, Dominik Stelzle, Kabemba E. Mwape, Tamara M. Welte, Hilde Strømme, Chishimba Mubanga, Wilbroad Mutale, Annette Abraham, Alex Hachangu, Veronika Schmidt, Chummy. S. Sikasunge, Isaac. K. Phiri, Andrea S. Winkler
doi: https://doi.org/10.1101/2022.12.21.22283765

Abstract

Background Taenia solium is a tapeworm that causes taeniosis in humans and cysticercosis in humans and pigs. Within Eastern and Southern Africa (ESA), there are many countries in which information on the presence of human taeniosis and cysticercosis is missing. This systematic review aimed to describe the current information available and gaps in the epidemiology of human T. solium infections in ESA.

Methods/Principle Findings Scientific literature published between 1st January 2000 and 20th June 2022 in international databases [MEDLINE (Ovid), Embase (Ovid), Global Health (Ovid), Scopus (Elsevier), African Index Medicus (via WHO Global Index Medicus), and Open Grey] was systematically reviewed for ESA following the PRISMA approach. The study area included 27 countries that make up the ESA region. Information on either taeniosis, cysticercosis or NCC was available for 16 of 27 countries within the region. Most case reports for cysticercosis and NCC were from South Africa, while Tanzania had the most aggregated cysticercosis reports. Eleven countries reported on NCC with seven countries reporting data on NCC and epilepsy. Unconfirmed human T. solium taeniosis cases were reported in nine countries while two countries (Madagascar and Zambia) reported confirmed T. solium cases. The cysticercosis seroprevalence ranged between 0.99 - 40.8% on antigen (Ag) tests and between 1.7 - 45.3% on antibody (Ab) tests, while NCC- suggestive lesions on brain CT scans showed a prevalence range between 1.0 - 76%. The human taeniosis prevalence based on microscopy ranged between 0.1 - 14.7%. Based on Copro Ag- ELISA studies conducted in Kenya, Rwanda, Tanzania, and Zambia, the highest prevalence of 19.7% was reported in Kenya

Conclusions Despite the public health and economic impact of T. solium in ESA, there are still large gaps in knowledge about the occurrence of the parasite, and the resulting One Health disease complex, and monitoring of T. solium taeniosis and cysticercosis is mostly not in place

Author summary Taenia solium is a tapeworm that causes three diseases, taeniosis in humans and cysticercosis in humans and pigs. Neurocysticercosis, which occurs when the central nervous system is involved has been associated with up to 57% of epilepsy cases in sub–Saharan Africa. Diagnosing neurocysticercosis among people with epilepsy is vital to prevent further morbidity and mortality from the disease as well as to reduce the negative socio-cultural beliefs associated with epilepsy. Within Eastern and Southern Africa, there are many countries in which information on the presence of human taeniosis, cysticercosis and neurocysticercosis is missing. This systematic review aimed to describe the current information available and gaps in the epidemiology of human T. solium infections in Eastern and Southern Africa. We found that Information on either taeniosis, cysticercosis or NCC was available only for 16 of 27 countries within the region. We also found that most of the studies on T. solium taeniosis, cysticercosis and neurocysticercosis within the region have been done in Kenya, Madagascar, Mozambique, Rwanda, South Africa, Tanzania and Zambia. Understanding the epidemiology of T. solium infections is essential for monitoring, prevention and control of the disease complex in a One Health approach.

Introduction

Rationale

Taenia solium is a tapeworm that causes taeniosis in humans and cysticercosis in humans and pigs. The life cycle of T. solium involves pigs as intermediate hosts (cysticercosis) while humans are definitive hosts (taeniosis). Humans may also act as accidental intermediate hosts when larvae of the parasite settle in muscles, subcutaneous or organ tissues causing human cysticercosis (HC). If they lodge in the central nervous system (CNS), including the brain and the spinal cord, the disease is called neurocysticercosis (NCC) [1, 2]. An individual may also have cysticerci in the CNS as well as in other parts of the body, which is referred to as (neuro) cysticercosis. NCC may be asymptomatic, but it can also cause various neurological signs/symptoms such as epileptic seizures and epilepsy, chronic progressive headache, focal neurological deficits, signs and symptoms of increased intracranial pressure and in rare cases, death [3–5]. Globally, NCC is estimated to be responsible for 30% of cases of acquired epilepsy in endemic areas [6] and 22% in sub-Saharan Africa [7]. However, this proportion depends on the infection pressure of T. solium and thus may vary considerably.

T. solium is common in Asia and Latin America, especially in areas where pigs are reared under free-ranging conditions, where pork is eaten and where hygiene is limited [8, 9]. Hence, T. solium is also likely endemic in most African countries [10]. Nevertheless, information on the endemicity of T. solium is limited and there are many countries from which no published information is available for either human or porcine cysticercosis. The purpose of this review was to gather all published information on human T. solium infections (T. solium taeniosis/(neuro)cysticercosis (TSTC)) in eastern and southern Africa (ESA) within the period 1st January 2000 and 20th June 2022 and describe the gaps in the epidemiology of TSTC in this area.

Methods

The systematic review was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [11] (S1 Table). The review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (registration number: CRD 42022343072).

Search strategy

All published articles were searched using the electronic databases, MEDLINE (Ovid), Embase (Ovid), Global Health (Ovid), Scopus (Elsevier), African Index Medicus (via WHO Global Index Medicus), and Open Grey. The reference lists of included studies were also scanned to identify further eligible documents. The searches were conducted on 20th June 2022.

For all questions subject headings (where applicable) and text words describing T. solium taeniosis/cysticercosis/neurocysticercosis and prevalence, epidemiology, control, elimination, or eradication were searched. The search strategy was intended to obtain all available literature on human taeniosis, cysticercosis and neurocysticercosis in ESA conducted and published in the last 22 years. Grey literature was also searched for any relevant publications. The search terms for all databases can be found in (S1 File).

Procedures

Data management

Literature search results were uploaded to the bibliographic software Mendeley Desktop and Covidence. Duplicates were removed based on author names and titles. Screening questions based on the inclusion and exclusion criteria were developed and citation abstracts and full-text articles were uploaded.

Selection process

The selection process was conducted in two stages. Firstly, titles and abstracts were screened independently by two reviewers (GZ and CM) and then full-text reports were obtained by the same reviewers for a detailed assessment with respect to the inclusion criteria. For records that referred to the same study, only one was selected.

Data collection process

The data were collected using standardized data collection forms in Microsoft Excel (S2 File). Data extracted included demographic information, methodology, and all the relevant reported outcomes. GZ carried out the data extraction with verification by CM.

Data items

Predefined tables summarizing individual cases included the year of diagnosis, age, gender, the country where cases were detected, diagnostic method, and location of the lesion (for cysticercosis). Tables summarizing aggregated cases or prevalence data included country, level of data collection (e.g. national or regional), timeframe, number of cases (or prevalence proportion), number of people tested, and diagnostic method.

Eligibility criteria

Inclusion criteria

We included all studies describing human TSTC in ESA, which was defined as the area covered by the following countries/territories: Angola, Botswana, Burundi, Comoros, Djibouti, Eritrea, Ethiopia, Kenya, Lesotho, Madagascar, Malawi, Mauritius, Mayotte, Mozambique, Namibia, Reunion, Rwanda, Seychelles, Socotra, Somalia, Somaliland, South Africa, Eswatini (former Kingdom of Swaziland), Tanzania, Uganda, Zambia and Zimbabwe. Included in this review were studies that describe the epidemiology, disease occurrence, burden, prevalence, incidence, prevention and control of TSTC in any of the twenty-seven countries of ESA. All observational studies including case series and case reports and systematic reviews of such studies were included.

Only studies conducted between 1st January 2000 and 20th June 2022 were considered. No language limits were imposed on the search, although studies in languages other than English were only included if they could be adequately translated by using Google Translate.

Exclusion criteria

We excluded studies that did not concern T. solium, did not concern humans, did not report data from within ESA and studies conducted before 1st January 2000.

Risk of bias assessment

The risk of bias in the studies was assessed using items recommended by the Agency for Health Care Research and Quality (AHRQ) [12]. This assessment covered baseline characteristics, inclusion-exclusion criteria, confounding and modifying variables, performance bias, attrition bias, detection bias and reporting bias. Each of these factors was rated and categorized as low, or high risk of bias. If the information available was insufficient, the risk of bias was considered ’unsure’.

Statistical analyses

No statistical pooling of results was conducted and the findings of the review are presented in a narrative synthesis with tables and figures to aid data presentation. Prevalence data if not already provided were calculated using the numerator and denominator of the study sample. Data were analyzed separately for taeniosis, cysticercosis, and neurocysticercosis. For the latter two, data were also presented separately for the general population and people with epilepsy.

Ethical considerations

Ethical recommendation was not required for this review.

Results

Study selection

Our search yielded 2114 records of which 1198 were duplicates. Through screening of titles and abstracts, 776 (85%) records were excluded and for a further 8, no full text was found. Full-text assessment with respect to the inclusion criteria was performed on 132 records of which 19 (14%) were excluded (17 reported data described in other included studies, one did not concern T. solium, and one reported results outside the scope of the study). One hundred and thirteen (113) studies were finally included in the review. Of those, 49 were concerned with only (neuro) cysticercosis, 57 with taeniosis, and 7 with both cysticercosis and taeniosis. Of the 113 reports reviewed, 25 were case reports, 82 were cross-sectional, 3 cohort and 3 case-control studies. The flow diagram for the search is shown in (Fig 1). The reference for included studies is shown in (S2 Table).

Fig 1.
Fig 1.

PRISMA flow diagram

Risk of bias

The risk of bias assessment revealed that most studies had a low risk of reporting, detection, attrition and performance bias. However, 7 studies had a high risk of performance bias, 20 had a high risk of bias due to inadequate inclusion and exclusion criteria, and 45 articles had a high risk of bias due to confounding and modifying variables.

Results of individual studies

Human (neuro) cysticercosis

Information on human (neuro) cysticercosis was obtained from 62 sources. In total, 25 (40%) records provided individual information on NCC and CC. Twelve (48%) of these records were on NCC only, seven (28%) on CC and six (24%) on both NCC and CC. Thirty-seven (60%) records reported aggregated information on NCC and CC. Ten (27%) of these records were on NCC only, twenty-one (57%) on CC only, and six (16%) on both NCC and CC. Information on human neuro(cysticercosis) was available for 14 of 27 ESA countries. No reports were available for Angola, Botswana, Comoros, Djibouti, Eritrea, Ethiopia, Lesotho, Mayotte, Reunion, Seychelles, Socotra, Somaliland and Somalia.

Human cysticercosis case reports

Individual human CC cases during the period 2000 to 2022 were reported in 13 hospital case records from six of the ESA countries with, South Africa reporting four cases; Madagascar, Malawi, Rwanda and Tanzania reporting two cases each and Mauritius reporting one case (Table 1). Individual NCC cases were reported in 18 hospital records from eight of the ESA countries with South Africa reporting eight cases while Madagascar, Malawi and Zambia reported two cases each. Mozambique, Eswatini, Tanzania and Zimbabwe reported one case each (Table 2). All reports were based on individual patients presenting with various signs/symptoms, and investigations leading to their diagnosis of either CC or NCC. Twelve (48%) of the 25 case reports described only NCC diagnosed through the use of brain computed tomography (CT) scan (7) and magnetic resonance imaging (MRI) (5), while seven (28%) presented with CC affecting other organs i.e. bronchus, breast, abdomen, neck and subcutaneous tissue diagnosed through histopathology and other investigations. Six (24%) case reports were on patients who presented with both NCC and CC affecting other organs (disseminated CC). At a district hospital in Rwanda ten cases of cutaneous CC were reported with the youngest being only 2 months old [13]. The oldest reported case of NCC was from South Africa in an 86-year-old female with a pharyngeal cyst, cutaneous cysts and active brain cysts [14]. The median age in years was 41 (17 -48 year). Twenty-three (92%) of the case reports had information on the affected gender with 54% of the reported cases being female and 46% being male.

View this table:
Table 1.

Individual human cysticercosis case reports as detected through histopathology of sample specimens from patients in eastern and southern Africa (2000 - 2022)

View this table:
Table 2.

Individual human neurocysticercosis (NCC) case reports as detected by Brain CT in eastern and southern Africa (2000 - 2022)

Aggregated human cysticercosis

The number of aggregated human CC reports (community-based, cross-sectional studies) for the period 2000 to 2022 in ESA was 27 (Table 3). These were reports from 9 nine countries, the majority of which were conducted in Tanzania (n=7) followed by Madagascar (n=6) and Zambia (n=4). South Africa, Mozambique, Rwanda and Kenya had two reports each. For Burundi and Uganda one report each was available. There was great variation in the aggregated number of human CC cases across countries with over 2307 cases reported from Madagascar only. The number of human CC cases identified in other ESA countries in documents published between 2000 and 2022 is shown in (Fig 2) below.

Fig 2.
Fig 2.

Aggregated human cysticercosis cases reported in community-based cross-sectional studies in eastern and southern Africa between the years 2000 and 2022.

View this table:
Table 3.

Aggregated human cysticercosis cases identified in eastern and southern Africa (2000 - 2022).

To ascertain cases of aggregated human CC, various diagnostic methods were utilized in the included reports with eight (30%) studies employing a combination of antibody and antigen (Ab/Ag) based enzyme linked immunosorbent assay (ELISA), five (19%) employed Ag-ELISA, while three reports (11%) utilized a combination of Ag-ELISA and electroimmunotransfer blot assay (EITB). One report (4%) was based on postmortem findings of CC through full-body dissection [15]. The other methods used for CC diagnosis are shown in (Fig 3).

Fig 3.
Fig 3.

Diagnostic methods used for aggregated human cysticercosis cases in the included studies for eastern and southern Africa

The prevalence of human CC in ESA in different study populations showed wide variation within and between countries (Fig 4 and Table 3). The CC seroprevalence ranged between 0.99 – 40.8% on Ag tests and between 1.7 – 45.3% on Ab tests. The highest point prevalence was reported in Tanzania (45.3%) from a study conducted in the Mbozi area of Mbeya District [16].

Fig 4.
Fig 4.

The distribution of human cysticercosis seroprevalence in the included studies for eastern and southern Africa.

For the studies conducted within Tanzania, this was an outlier value. High prevalence variation was also observed within countries as seen in Madagascar, Rwanda, South Africa and Zambia (Fig 5). The lowest point prevalence (0.99%) was also reported from Tanzania. For details on sources refer to Table 3.

Fig 5.
Fig 5.

Prevalence of human cysticercosis in eastern and southern Africa based on serology data in reviewed studies with high variation observed in Rwanda, South Africa, Tanzania and Zambia

Aggregated human neurocysticercosis

For reports presenting aggregated NCC cases (Table 4), 16 records were available. Four (25%) employed imaging (brain CT or MRI) only, whereas 11 (69%) incorporated both imaging and serological tests, and one (6%) was based on postmortem full-body dissection. The NCC- suggestive lesions on brain CT scans showed a prevalence range between 1.0 – 76% in different study populations in ESA (Fig 6 and Table 4).

Fig 6.
Fig 6.

The distribution of human neurocysticercosis prevalence based on imaging data in reviewed studies in eastern and southern Africa. *Prevalence based on MRI

View this table:
Table 4.

Aggregated human neurocysticercosis cases as detected by Brain CT scan in eastern and southern Africa (2000 - 2022)

One report utilized MRI to identify lesions suggestive of NCC in HIV+ children. In this report, four children (8.5% of the total) were found to have NCC, with imaging suggesting the vesicular (active) stage of NCC in all of them [17].

Neurocysticercosis and epilepsy

Among the 16 records reporting aggregated NCC, nine (56%) reported data linking NCC and epilepsy (Table 5). Three of these records were reported from South Africa whereas one record each was reported from Kenya, Mozambique, Namibia, Rwanda, Tanzania and Zambia. Three (33%) of these NCC epilepsy studies were community-based studies and six (67%) were conducted in hospital/health facility settings. The prevalence of NCC among people with epilepsy ranged between 0 – 61%. One study in Kenya in a T. solium endemic area found none of the participants with epilepsy had serological evidence of cysticercosis and none had radiographic findings consistent with NCC [18]. Whereas at St Elizabeth’s Hospital, Lusikisiki, Eastern Cape, 61% of the patients presenting with epilepsy had NCC associated epilepsy, the prevalence being highest in the 10 - 19-year-old age group [19]. For details on sources refer to Table 5.

View this table:
Table 5.

Human neurocysticercosis with epilepsy as detected by Brain CT scan in eastern and southern Africa (2000 - 2022).

Human taeniosis

A total of 64 records were identified providing information on taeniosis cases in ESA for the period 2000 to 2022 (Table 6). These records were reported in 11 out of 27 ESA countries (Fig 7) with Ethiopia reporting the most records (n=38) followed by Tanzania (n=6) and Zambia (n=5). Kenya and Uganda had three records each while Angola, Mozambique, and South Africa had two records each. Malawi, Madagascar and Rwanda had one record each. There were no cases reported from Botswana, Burundi, Comoros, Djibouti, Eritrea, Lesotho, Mauritius, Mayotte, Namibia, Reunion, Seychelles, Socotra, Somalia, Somaliland, Swaziland, and Zimbabwe.

Fig 7.
Fig 7.

The distribution of human taeniosis in eastern and southern Africa showing prevalence data on microscopy and *prevalence based on serology (rES33-immunoblot, Ag-ELISA), and Copro-Ag ELISA)

View this table:
Table 6.

Aggregated human taeniosis cases detected by stool microscopy and reported as Taenia spp in eastern and southern Africa (2000 - 2022).

Several groups of people were studied for human taeniosis with 25 records reporting taeniosis cases in school children, 18 records on patients presenting at health facilities, 15 on consenting community volunteers, and six on food handlers. There was great variation in aggregated numbers of human taeniosis cases across countries with 595 cases reported from Ethiopia alone and even more (4834) reported from Mozambique. The number of human taeniosis cases identified for the other nine countries in ESA is shown in (Fig 8).

Fig 8.
Fig 8.

Taeniosis cases reported in eastern and southern Africa between 2000 – 2020

The largest number of cases were reported as Taenia spp. (Table 6) without specifying the type of species. In only two records from Madagascar and Zambia, T. solium was confirmed using PCR [20, 21]. Microscopy only was employed for 53 studies, and copro Ag-ELISA only in three studies. Five studies used both copro Ag-ELISA and microscopy for taeniosis diagnosis. Three studies used the rES33 EITB for the presence of a tapeworm antibodies in the body. Immunological data (copro Ag-ELISA or rES33 EITB) on taeniosis was only available from Kenya, Rwanda, Tanzania, and Zambia.

Within the ESA region, the prevalence of human taeniosis based on microscopy ranged between 0.1 - 14.7% with the highest prevalence reported in a study conducted among food handlers at Wolkite University in Ethiopia [22] (Figs 7 and 9). Among studies based on copro Ag-ELISA conducted in Kenya, Rwanda, Tanzania, and Zambia, the highest prevalence was reported in Kenya at 19.7% [23]. Rwanda had a taeniosis prevalence of 1.4% [24], Tanzania ranged between 0.5 to 5.2% [16, 25] [16], [22] and Zambia ranged between 0.3 to 13.8% [20, 26] (Fig 10). For details on sources refer to Table 6.

Fig 9.
Fig 9.

Prevalence of taeniosis in eastern and southern Africa based on microscopy data in reviewed studies

Fig 10.
Fig 10.

Prevalence of taeniosis based on copro-Ag ELISA in reviewed studies in eastern and southern Africa.

Discussion

This study aimed at collecting epidemiological data on T. solium infections in humans in the ESA region for the period 2000 to 2022. For both cysticercosis and taeniosis, there was no data from Comoros, Djibouti, Eritrea, Mayotte, Reunion, Seychelles, Socotra, Somalia and Somaliland that could be retrieved. Somalia has for some time now experienced internal conflicts and this may have a bearing on the diagnosis and reporting of human cysticercosis and taeniosis cases. For the other six island states and territories, a lack of scientific interest in reporting cases has been cited [27]. The same can be said about Botswana and Lesotho from which data on cysticercosis and taeniosis was also lacking. Cysticercosis data was lacking in even more countries.

According to the World Bank IBRD-IDA report of 2022 [28] the population using safely managed sanitation services for both Comoros and Djibouti only stood at 37% with no data for other island states. People practicing open defecation were higher in Eritrea (67%) with Somalia reporting (23%) and Djibouti (16%). On the Réunion island, pork is said to be the most popular meat with a total annual pork consumption of about 20 000 tones. Half of this is produced on the island and the rest is imported frozen from Europe [29]. Comoros on the other hand has a small livestock sector with most of its meat including pork imported from Tanzania, Madagascar and France [30]. Seventy per cent of the Somali human population subsists in pastoralism with sheep and goats being the dominant animals. Camels are primarily raised for milk production and small ruminants are for generating cash income for the family [31]. For Mayotte, Eritrea and Djibouti, information on pig rearing could not be found as these countries focus mostly on cattle, sheep, goats, and camels [32]. However, for Eritrea, pig breeding has recently begun to be promoted [33] and so is the case for Seychelles whose 2011 census of agriculture showed that 2% (483/24770) of the households were raising pigs in small holdings [34]. Therefore, while it is not possible to ascertain the presence or absence of human T. solium infections in these countries, there is a possibility that these infections do exist as pork consumption seems to be practiced and risk factors are present; some countries even import pork from confirmed T. solium endemic countries. Therefore, the numbers collected for this review represent an underestimation of the T. solium epidemiology for human disease in ESA.

Regarding human cysticercosis cases, tapeworm carriers are the sole cause of infection in both rural and urban areas of the ESA region [10, 35]. Tapeworm carriers, if not treated, pose a risk to themselves if they ingest infective eggs leading to cysticercosis but can also pose a risk to other people in contact [21, 36]. A study in Madagascar found at a household level, the overall seroprevalence of IgG detected by Ab-ELISA and EITB within the same household in which a tapeworm carrier has been detected was 46% and 34% respectively [21]. Individual human cysticercosis cases were identified from a third of the 27 ESA countries. South Africa reported the highest number of individual human cysticercosis cases followed by Madagascar. This could be due to increased awareness of cysticercosis as a possible diagnosis in, for example, people with epilepsy in these countries compared to other countries within the region. South Africa also has more resources compared to the other countries within the region. For example, as early as 2003 South Africa already had 214 CT scans and 111 neurologists. This is an advantage in terms of diagnosis and management of particularly NCC that is not present in other countries within the region [37]. With poor pig management, poor meat inspection, and poor sanitation those who do not eat pork are equally at risk of infection with cysticercosis as those eating pork [38–40]. Additionally, certain cultural practices within the region have also been cited as contributing factors to cysticercosis. For example, in South Africa, it has been reported that some unqualified traditional healers “baloi” used Taenia segments and added them to medicinal mixtures as strengthening ingredients. There are also reports of T. solium segments being added to the beer of unfaithful husbands or lovers as punishment [37].

NCC has been associated with up to 57% of epilepsy cases in sub–Saharan Africa to which the region under consideration belongs [7, 41]. This is higher than the global average of 30% of NCC among PWE [6]. This association is higher than the global average of 30% [6]. For most countries within ESA, the diagnosis of NCC is problematic due to the scarcity of neuroimaging, serology and trained neurologists [42, 43]. This diagnostic challenge is not only present in ESA but also in Europe where a lack of awareness of NCC leads to underdiagnoses [44]. Only a quarter of the countries within the ESA reported data on NCC and epilepsy. Epilepsy is one of the most common neurological disorders in many parts of sub-Saharan Africa and NCC seems to be a major cause of it in T. solium cysticercosis endemic areas. Diagnosing NCC among people with epilepsy is vital to prevent further morbidity and mortality from the disease as well as to reduce the negative socio-cultural beliefs associated with epilepsy in the region [42,45–47].

Regarding human T. solium taeniosis in ESA, only Kenya, Madagascar, Rwanda, Tanzania, and Zambia conducted community-based studies and employed serological tests that specifically aimed at determining the burden of infection. The other countries reported data on taeniosis as incidental findings following microscopic examinations of stool samples conducted for soil- transmitted helminths. The reported human taeniosis cases were also reported on an aggregated level without evidence of species determination. Thus, cases reported as either taeniosis or taenia spp could not for instance be differentiated from cases due to T. saginata which is also widely distributed in ESA [27]. Only two studies, one from Madagascar and another from Zambia were able to confirm the T. solium species after collecting tapeworm proglottids [20, 21].

This lack of species differentiation creates uncertainty regarding the epidemiology of T. solium infections in ESA. There is therefore a possible underestimation of the magnitude of T. solium taeniosis in the region. This is worsened by the fact that T. solium taeniosis is not even a notifiable disease in most of these countries. Application of molecular methods to differentiate T. solium species on stool examination is not widely practiced and it is difficult to differentiate taenia eggs based on microscopy [35, 48]. More sensitive and specific diagnostic tools need to be used to identify the true prevalence and outline the epidemiology of T. solium.

Human taeniosis in the region is due to the high prevalence of porcine cysticercosis in ESA countries which is ranked amongst the highest in the world [10]. Over the last decade, pig production as a risk factor for human taeniosis in the rural communities of ESA countries has increased mainly because pig raising is an attractive alternative to other animals as it does not require grazing land compared to ruminants. Free-range pig keeping is popular, especially in rural areas of the region as it is easy and cheap. This coupled with the general lack of slaughterhouses and inspection of pork with a lack of sanitation facilities has contributed to the risk for people to attract taeniosis and cysticercosis [3,10,49].

Study limitation

Our study is limited by the fact that search platforms were used only for online publications. Thus, unpublished data which could have contributed significantly to a more nuanced picture of the epidemiology of human T. solium infections in ESA could have been missed. Another limitation of our study is the difficulty in comparing epidemiological data from different study populations using different diagnostic tests used and the different diagnostic approaches.

Conclusion

In this review on human T. solium taeniosis and (neuro) cysticercosis within ESA, we found wide variations in the prevailing prevalent estimates depending on the quality of the study and the diagnostic methods used. There remain large gaps with regards to T. solium infections within the ESA region with 11 countries without any information on human taeniosis and cysticercosis, and even more countries (18) without any information for cysticercosis.

Considering the public health and economic impact that T. solium infections have, it is important to understand its epidemiology in humans. Human taeniosis, cysticercosis and NCC cases need to be reported and notified to public health authorities. More community-based surveys as well as ante-mortem and postmortem porcine surveys must be conducted for control and surveillance purposes. Lack of awareness about the presence of T. solium among medical, community and government authorities including inadequate technology for diagnosis of taeniosis, cysticercosis and NCC, in both humans and pigs (cysticercosis) remains a challenge that needs to be addressed for proper surveillance, prevention and control.

Data Availability

All references found eligible in our review are included in the supplementary materials (S2 Table).

Supplement

S1 File. Documentation of literature search. (DOCX)

S2 File. Data collection forms. (DOCX)

S1 Table. PRISMA 2020 checklist. (DOCX)

S2 Table. References retrieved through online international databases. (XLS)

Funding

This study was fully funded by the German Federal Ministry of Education and Research (BMBF) under CYSTINET-Africa 2018-Mar-002 and 01KA1618. The funder had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.

Availability of data and material

All references found eligible in our review are included in the supplementary materials (S2 Table).

Competing interests

The authors declare that they have no competing interests.

Author contributions

GZ, CM and HS conducted the systematic review of the literature and extracted data. GZ analysed the data and drafted the first version of the manuscript. AA, ASW, CM, DS, GZ, IGK, KEM, VS contributed to the design of the study. All authors contributed to interpretation of data and writing of the paper. All authors read and approved the final manuscript.

Acknowledgment

None.

Footnotes

  • ↵& These authors contributed equally to this work.

References

  1. [1].↵
    J. Sotelo, O.H. Del Brutto, Review of neurocysticercosis, Neurosurg. Focus. 12 (2002) e1. https://doi.org/10.3171/foc.2002.12.6.2.
  2. [2].↵
    K.D. Murrell, WHO/FAO/OIE guidelines for the surveillance, prevention and control of taeniosis/cysticercosis. Paris: World Health Organisation for Animal Health (OIE), 2005, 2005. http://www.oie.int (accessed May 6, 2019).
  3. [3].↵
    H. Carabin, A. Millogo, A. Cissé, S. Gabriël, I. Sahlu, P. Dorny, C. Bauer, Z. Tarnagda, L.D. Cowan, R. Ganaba, Prevalence of and Factors Associated with Human Cysticercosis in 60 Villages in Three Provinces of Burkina Faso, PLoS Negl. Trop. Dis. 9 (2015) e0004248. https://doi.org/10.1371/journal.pntd.0004248.
    OpenUrl
  4. [4].
    A. Winkler, H. Richter, Landscape analysis : management of neurocysticercosis with an emphasis on low- and middle-income countries, World Heal. Organ. (2015) 65. www.neurokopfzentrum.med.tum.de/neurologie/42b.html (accessed February 22, 2018).
  5. [5].↵
    D. Stelzle, V. Schmidt, L. Keller, B.J. Ngowi, W. Matuja, G. Escheu, P. Hauke, V. Richter, E. Ovuga, B. Pfausler, E. Schmutzhard, A. Amos, W. Harrison, J. Kaducu, A.S. Winkler, Characteristics of people with epilepsy and Neurocysticercosis in three eastern African countries–A pooled analysis, PLoS Negl. Trop. Dis. 16 (2022) e0010870. https://doi.org/10.1371/journal.pntd.0010870.
    OpenUrl
  6. [6].↵
    P.C. Ndimubanzi, H. Carabin, C.M. Budke, H. Nguyen, Y.J. Qian, E. Rainwater, M. Dickey, S. Reynolds, J.A. Stoner, A systematic review of the frequency of neurocyticercosis with a focus on people with epilepsy, PLoS Negl. Trop. Dis. 4 (2010) e870. https://doi.org/10.1371/journal.pntd.0000870.
    OpenUrlCrossRefPubMed
  7. [7].↵
    L.F. Owolabi, B. Adamu, A.M. Jibo, S.D. Owolabi, A.I. Imam, I.D. Alhaji, Neurocysticercosis in people with epilepsy in Sub-Saharan Africa: A systematic review and meta-analysis of the prevalence and strength of association, SeizureEuropean J. Epilepsy. 76 (2020) 1–11. https://doi.org/10.1016/j.seizure.2020.01.005.
    OpenUrl
  8. [8].↵
    E. Bruno, A. Bartoloni, L. Zammarchi, M. Strohmeyer, F. Bartalesi, J. Bustos, S. Santivañez, H.H. Garcia, A. Nicoletti, M. Bonati, F. Severino, V. Confalonieri, C. Pandolfini, Z. Bisoffi, D. Buonfrate, A. Angheben, M. Albonico, J. Muñoz, R. Pool, A. Requena-Mendez, M. Roura, A. Hardon, C. Pell, P. Chiodini, J. Moreira, R. Sempértegui, M. Anselmi, E. Gotuzzo, M.A. Mena, F. Torrico, D. Lozano, G.C. Rojas, T.H. Cabrera, J.O. Morón, I.A. Cuellar, J.A. Suarez, G. Tognoni, C.L. Caro, Epilepsy and Neurocysticercosis in Latin America: A Systematic Review and Meta-analysis, PLoS Negl. Trop. Dis. 7 (2013). https://doi.org/10.1371/journal.pntd.0002480.
  9. [9].↵
    D. Ng-Nguyen, R.J. Traub, V.A.T. Nguyen, K. Breen, M.A. Stevenson, Spatial distribution of Taenia solium exposure in humans and pigs in the Central Highlands of Vietnam, PLoS Negl. Trop. Dis. 12 (2018). https://doi.org/10.1371/journal.pntd.0006810.
  10. [10].↵
    I.K. Phiri, H. Ngowi, S. Afonso, E. Matenga, M. Boa, S. Mukaratirwa, S. Githigia, M. Saimo, C. Sikasunge, N. Maingi, G.W. Lubega, A. Kassuku, L. Michael, S. Siziya, R.C. Krecek, E. Noormahomed, M. Vilhena, P. Dorny, A.L. Willingham, The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk, in: Acta Trop., Elsevier, 2003: pp. 13–23. https://doi.org/10.1016/S0001-706X(03)00051-2.
  11. [11].↵
    M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hróbjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuinness, L.A. Stewart, J. Thomas, A.C. Tricco, V.A. Welch, P. Whiting, D. Moher, The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, BMJ. 372 (2021). https://doi.org/10.1136/bmj.n71.
  12. [12].↵
    M. Viswanathan, A. MT, N. Berkman, S. Chang, L. Hartling, M., et al. McPheeters, Assessing the risk of bias of individual studies in systematic reviews of health care interventions - methods guide – chapter | AHRQ effective health care program, (2016). www.effectivehealthcare.ahrq.gov. (accessed September 7, 2018).
  13. [13].↵
    M. Mugabe, D. Ruhangaza, E. Hakizimana, Cysticercosis: Report of 10 cases diagnosed at a district hospital in Rwanda, Mod. Pathol. 32 (2019). http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emexb&NEWS=N&AN=631814441.
  14. [14].↵
    S. Sobnach, S.A. Khosa, S. Pather, S. Longhurst, D. Kahn, P.J. Raubenheimer, First case report of pharyngeal cysticercosis, Trans. R. Soc. Trop. Med. Hyg. 103 (2009) 206–208. https://doi.org/10.1016/j.trstmh.2008.08.017.
    OpenUrlCrossRefPubMed
  15. [15].↵
    C. Himwaze, L.A. Mucheleng’anga, V. Telendiy, A. Hamukale, J. Tembo, N. Kapata, F. Ntoumi, A. Zumla, Cardiac cysticercosis and neurocysticercosis in sudden and unexpected community deaths in Lusaka, Zambia: a descriptive medico-legal post-mortem examination study, Int. J. Infect. Dis. 115 (2022) 195–200. https://doi.org/10.1016/j.ijid.2021.11.042.
    OpenUrl
  16. [16].↵
    G. Mwanjali, C. Kihamia, D.V.C. Kakoko, F. Lekule, H. Ngowi, M.V. Johansen, S.M. Thamsborg, A.L. Willingham, Prevalence and Risk Factors Associated with Human Taenia Solium Infections in Mbozi District, Mbeya Region, Tanzania, PLoS Negl. Trop. Dis. 7 (2013) e2102. https://doi.org/10.1371/journal.pntd.0002102.
    OpenUrlCrossRefPubMed
  17. [17].↵
    A. Buda, O. Dean, H.R. Adams, S. Mwanza-Kabaghe, M.J. Potchen, E.G. Mbewe, P.P. Kabundula, S.M. Moghaddam, M. Mweemba, B. Matoka, M.M. Mathews, G.L. Birbeck, D.R. Bearden, Neurocysticercosis Among Zambian Children and Adolescents With Human Immunodeficiency Virus: A Geographic Information Systems Approach, Pediatr. Neurol. 102 (2020) 36–43. https://doi.org/10.1016/j.pediatrneurol.2019.07.017.
    OpenUrl
  18. [18].↵
    M.M. Diaz, D. Sokhi, J. Noh, A.K. Ngugi, F.J. Minja, P. Reddi, E.M. Fèvre, A.-C.L. Meyer, Prevalence of Epilepsy, Human Cysticercosis, and Porcine Cysticercosis in Western Kenya, Am. J. Trop. Med. Hyg. 106 (2022) 1450–1455. https://doi.org/10.4269/ajtmh.21-0594.
    OpenUrl
  19. [19].↵
    G.S. Ocana, J.C.O. Sablon, I.O. Tamayo, L.A. Arena, L.M.S. Ocana, S. Govender, Neurocysticercosis in patients presenting with epilepsy at St. Elizabeth’s Hospital, Lusikisiki, South African Med. J. 99 (2009) 588–591. https://doi.org/10.7196/SAMJ.3358.
    OpenUrl
  20. [20].↵
    K.E. Mwape, I.K. Phiri, N. Praet, J.B. Muma, G. Zulu, P. van den Bossche, R. de Deken, N. Speybroeck, P. Dorny, S. Gabriël, Taenia solium infections in a rural area of Eastern Zambia-A community based study, PLoS Negl. Trop. Dis. 6 (2012) 1–9. https://doi.org/10.1371/journal.pntd.0001594.
    OpenUrlCrossRef
  21. [21].↵
    A. Rahantamalala, R.L. Rakotoarison, E. Rakotomalala, M. Rakotondrazaka, J. Kiernan, P.M. Castle, L. Hakami, K. Choi, A.S. Rafalimanantsoa, A. Harimanana, P. Wright, S.G. Lapierre, M. Schoenhals, P.M. Small, L.A. Marcos, I. Vigan-Womas, Prevalence and factors associated with human Taenia solium taeniosis and cysticercosis in twelve remote villages of Ranomafana rainforest, Madagascar, PLoS Negl. Trop. Dis. 16 (2022) e0010265. https://doi.org/10.1371/journal.pntd.0010265.
    OpenUrl
  22. [22].↵
    T.A. Bafa, E.M. Sherif, A.H. Hantalo, G.G. Woldeamanuel, Magnitude of enteropathogens and associated factors among apparently healthy food handlers at Wolkite University Student’s Cafeteria, Southern Ethiopia, BMC Res. Notes. 12 (2019) 1–6. https://doi.org/10.1186/s13104-019-4599-z.
    OpenUrl
  23. [23].↵
    E.M. Fèvre, W.A. de Glanville, L.F. Thomas, E.A.J. Cook, S. Kariuki, C.N. Wamae, An integrated study of human and animal infectious disease in the Lake Victoria crescent small-holder crop-livestock production system, Kenya, BMC Infect. Dis. 17 (2017) 1–14. https://doi.org/10.1186/s12879-017-2559-6.
    OpenUrlCrossRefPubMed
  24. [24].↵
    L. Acosta Soto, L.A. Parker, M.J. Irisarri-Gutiérrez, J.A. Bustos, Y. Castillo, E. Perez, C. Muñoz-Antoli, J.G. Esteban, H.H. García, F.J. Bornay-Llinares, Evidence for Transmission of Taenia solium Taeniasis/Cysticercosis in a Rural Area of Northern Rwanda, Front. Vet. Sci. 8 (2021) 237. https://doi.org/10.3389/fvets.2021.645076.
    OpenUrl
  25. [25].↵
    U.C. Braae, P. Magnussen, B. Ndawi, W. Harrison, F. Lekule, M.V. Johansen, Effect of repeated mass drug administration with praziquantel and track and treat of taeniosis cases on the prevalence of taeniosis in Taenia solium endemic rural communities of Tanzania, Acta Trop. 165 (2017) 246–251. https://doi.org/10.1016/j.actatropica.2015.10.012.
    OpenUrlCrossRef
  26. [26].↵
    K.E. Mwape, I.K. Phiri, N. Praet, P. Dorny, J.B. Muma, G. Zulu, N. Speybroeck, S. Gabriël, Study and ranking of determinants of taenia solium infections by classification tree models, Am. J. Trop. Med. Hyg. 92 (2015) 56–63. https://doi.org/10.4269/ajtmh.13-0593.
    OpenUrlAbstract/FREE Full Text
  27. [27].↵
    V. Dermauw, P. Dorny, U.C. Braae, B. Devleesschauwer, L.J. Robertson, A. Saratsis, L.F. Thomas, Epidemiology of Taenia saginata taeniosis/cysticercosis: A systematic review of the distribution in southern and eastern Africa, Parasites and Vectors. 11 (2018) 578. https://doi.org/10.1186/s13071-018-3163-3.
    OpenUrl
  28. [28].↵
    The World Bank IBRD-IDA, Countries | Data, (2022). https://data.worldbank.org/country (accessed November 17, 2022).
  29. [29].↵
    L. Phillips, Successful meat production on Réunion Island, Farmer’s Wkly. (2014). https://www.farmersweekly.co.za/animals/cattle/successful-meat-production-on-reunion-island/ (accessed September 27, 2022).
  30. [30].↵
    H.C. Metz, Comoros: A Country Study, Washingt. GPO Libr. Congr. (1994). http://countrystudies.us/comoros/ (accessed September 27, 2022).
  31. [31].↵
    A.A. Elmi, Livestock production in Somalia with special emphasis on camels, Nomad. People. 29 (1991) 87–103. https://www.jstor.org/stable/43123342 (accessed November 17, 2022).
    OpenUrl
  32. [32].↵
    EAFF 2022, East Africa Farmers Federation, (n.d.). https://www.eaffu.org/djibouti/ (accessed September 23, 2022).
  33. [33].↵
    Eritrea Ministry of Information, Livestock Population and Types, (2012). https://shabait.com/2012/12/24/livestock-population-and-types-of-eritrea/ (accessed September 27, 2022).
  34. [34].↵
    , Mr Marc Naiken; , Ms. Laura Ah Time, Seychelles Census of Agriculture, (2011). https://wedocs.unep.org/xmlui/handle/20.500.11822/9520 (accessed November 17, 2022).
  35. [35].↵
    K.E. Mwape, S. Gabriël, The Parasitological, Immunological, and Molecular Diagnosis of Human Taeniasis with Special Emphasis on Taenia solium Taeniasis, Curr. Trop. Med. Reports. 1 (2014) 173–180. https://doi.org/10.1007/s40475-014-0028-5.
    OpenUrl
  36. [36].↵
    H.H. Garcia, O.H. Del Brutto, Neurocysticercosis: Updated concepts about an old disease, Lancet Neurol. 4 (2005) 653–661. https://doi.org/10.1016/S1474-4422(05)70194-0.
    OpenUrlCrossRefPubMedWeb of Science
  37. [37].↵
    N.A. Mafojane, C.C. Appleton, R.C. Krecek, L.M. Michael, A.L. Willingham, The current status of neurocysticercosis in Eastern and Southern Africa, in: Acta Trop., Elsevier, 2003: pp. 25–33. https://doi.org/10.1016/S0001-706X(03)00052-4.
  38. [38].↵
    H.J. Heinz, G.M. Macnab, Cysticercosis in the Bantu of southern Africa., S. Afr. J. Med. Sci. 30 (1965) 19–31. https://pubmed.ncbi.nlm.nih.gov/5854976/ (accessed May 15, 2022).
    OpenUrlPubMed
  39. [39].
    I.K. Phiri, P. Dorny, S. Gabriel, A.L. Willingham, N. Speybroeck, J. Vercruysse, The prevalence of porcine cysticercosis in Eastern and Southern provinces of Zambia, Vet. Parasitol. 108 (2002) 31–39. https://doi.org/10.1016/S0304-4017(02)00165-6.
    OpenUrlCrossRefPubMed
  40. [40].↵
    F. Jansen, P. Dorny, S. Gabriël, V. Dermauw, M.V. Johansen, C. Trevisan, The survival and dispersal of Taenia eggs in the environment: what are the implications for transmission? A systematic review, Parasites and Vectors. 14 (2021) 1–16. https://doi.org/10.1186/s13071-021-04589-6.
    OpenUrl
  41. [41].↵
    K.E. Mwape, J. Blocher, J. Wiefek, K. Schmidt, P. Dorny, N. Praet, C. Chiluba, H. Schmidt, I.K. Phiri, A.S. Winkler, S. Gabriël, Prevalence of neurocysticercosis in people with epilepsy in the Eastern province of Zambia, PLoS Negl. Trop. Dis. 9 (2015) e0003972. https://doi.org/10.1371/journal.pntd.0003972.
    OpenUrlCrossRef
  42. [42].↵
    A. Winkler, Sylvia, Epilepsy and Neurocysticercosis in Sub-Saharan Africa, Nov. Asp. Cysticercosis Neurocysticercosis. (2013). https://doi.org/10.5772/53289.
  43. [43].↵
    A. Millogo, A. Kongnyu Njamnshi, M. Kabwa-PierreLuabeya, Neurocysticercosis and epilepsy in sub-Saharan Africa, Brain Res. Bull. 145 (2019) 30–38. https://doi.org/10.1016/j.brainresbull.2018.08.011.
    OpenUrlCrossRef
  44. [44].↵
    M. Laranjo-González, B. Devleesschauwer, C. Trevisan, A. Allepuz, S. Sotiraki, A. Abraham, M.B. Afonso, J. Blocher, L. Cardoso, J.M. Correia Da Costa, P. Dorny, S. Gabriël, J. Gomes, M.Á. Gómez-Morales, P. Jokelainen, M. Kaminski, B. Krt, P. Magnussen, L.J. Robertson, V. Schmidt, E. Schmutzhard, G.S.A. Smit, B. Šoba, C.R. Stensvold, J. Starič, K. Troell, A.V. Rataj, M. Vieira-Pinto, M. Vilhena, N.A. Wardrop, A.S. Winkler, V. Dermauw, Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe, Parasites and Vectors. 10 (2017) 1–14. https://doi.org/10.1186/s13071-017-2280-8.
    OpenUrlCrossRef
  45. [45].↵
    R. Baskind, G.L. Birbeck, Epilepsy-associated stigma in sub-Saharan Africa: The social landscape of a disease, Epilepsy Behav. 7 (2005) 68–73. https://doi.org/10.1016/J.YEBEH.2005.04.009.
    OpenUrlCrossRefPubMedWeb of Science
  46. [46].
    M. Atadzhanov, A. Haworth, E.N. Chomba, E.K. Mbewe, G.L. Birbeck, Epilepsy- associated stigma in Zambia: what factors predict greater felt stigma in a highly stigmatized population?, Epilepsy Behav. 19 (2010) 414–8. https://doi.org/10.1016/j.yebeh.2010.08.017.
    OpenUrlCrossRefPubMedWeb of Science
  47. [47].↵
    M.T. Medina, R.L. Aguilar-Estrada, A. Alvarez, R.M. Durõn, L. Martínez, S. Dubõn, A.L. Estrada, C. Zúniga, D. Cartagena, A. Thompson, E. Ramirez, L. Banegas, J.R. Osorio, A. V. Delgado-Escueta, J.S. Collins, K.R. Holden, Reduction in rate of epilepsy from neurocysticercosis by community interventions: The Salamá, Honduras study, Epilepsia. 52 (2011) 1177–1185. https://doi.org/10.1111/j.1528-1167.2010.02945.x.
    OpenUrlCrossRefPubMedWeb of Science
  48. [48].↵
    J.S. McCarthy, S. Lustigman, G.J. Yang, R.M. Barakat, H.H. García, B. Sripa, A.L. Willingham, R.K. Prichard, M.G. Basáñez, A research agenda for helminth diseases of humans: Diagnostics for control and elimination programmes, PLoS Negl. Trop. Dis. 6 (2012). https://doi.org/10.1371/journal.pntd.0001601.
  49. [49].↵
    S. Thys, K.E. Mwape, P. Lefèvre, P. Dorny, T. Marcotty, A.M. Phiri, I.K. Phiri, S. Gabriël, Why Latrines Are Not Used: Communities’ Perceptions and Practices Regarding Latrines in a Taenia solium Endemic Rural Area in Eastern Zambia, PLoS Negl. Trop. Dis. 9 (2015) e0003570. https://doi.org/10.1371/journal.pntd.0003570.
    OpenUrl
  50. [50].
    F.R. Rabenjamina, J. Ranaivoravo, V. Raholimina, A. Ramialiharisoa, A case report of bronchial cysticercosis, Arch. Inst. Pasteur Madagascar. 66 (2000) 43–45. https://europepmc.org/article/med/12463034 (accessed October 23, 2021).
    OpenUrlPubMed
  51. [51].
    H.N. Rakoto-Ratsimba, S.S.E.N. Rabesalama, H.J.C. Razafimahandry, A. Ranaivozanany, Case report of solitary breast cysticercosis in Madagascar, Med. Trop. 67 (2007) 179–180. https://pubmed.ncbi.nlm.nih.gov/17691439/ (accessed October 18, 2021).
    OpenUrl
  52. [52].
    T. Heller, C. Wallrauch, D. Kaminstein, S. Phiri, Case report: Cysticercosis: sonographic diagnosis of a treatable cause of epilepsy and skin nodules, Am. J. Trop. Med. Hyg. 97 (2017) 1827–1829. https://doi.org/10.4269/ajtmh.17-0257.
    OpenUrl
  53. [53].
    S.J. Uledi, A rare gigantic solitary cysticercosis pseudotumour of the neck, J. Surg. Case Reports. 2010 (2010) 5–5. https://doi.org/10.1093/jscr/2010.9.5.
    OpenUrl
  54. [54].
    S. Agnihotri, O.P. Talwar, S. Pudasaini, R. Baral, Cysticercosis of breast - A case report, Polish J. Pathol. 57 (2006) 53–54. https://doi.org/10.3348/jkrs.1995.32.5.835.
    OpenUrl
  55. [55].
    J. Tuan, L. Kailani, P. Ngabitsinze, S. Umuganwa, F. Munyaneza, E. Musoni, A.L. Canales, M. Nkeshimana, Disseminated cysticercosis in rwanda—case report of a patient presenting with difficulty with walking and skin nodules, Rwanda Med. J. 77 (2020) 1–4. https://www.google.com/search?q=Disseminated+cysticercosis+in+rwanda—case+report+of+a+patient+presenting+with+difficulty+with+walking+and+skin+nodules&oq=Disseminated+cysticercosis+in+rwanda—case+report+of+a+patient+presenting+with+difficulty+with+walking (accessed July 5, 2022).
    OpenUrl
  56. [56].
    M.B. Thomas, K.M. Thomas, A.A. Awotedu, E. Blanco-Blanco, M. Anwary, Cardiocysticercosis, SAMJ South African Med. J. 97 (2007) 504–506. https://go.gale.com/ps/i.do?p=AONE&sw=w&issn=02569574&v=2.1&it=r&id=GALE%7CA167881603&sid=googleScholar&linkaccess=fulltext (accessed October 24, 2021).
    OpenUrl
  57. [57].
    E. Agaba, D. Modi, O. Gunduz, Z. Modi, Subcutaneous nodules of cysticercosis as a sign of asymptomatic neurocysticercosis in an HIV positive patient, Rev. Soc. Bras. Med. Trop. 51 (2018) 861–863. https://doi.org/10.1590/0037-8682-0178-2018.
    OpenUrl
  58. [58].
    Z. Nowalaza, M. Zampoli, K. Pillay, S. Singh, H.J. Zar, Pulmonary cysticercosis in an urban South African child, Pediatr. Pulmonol. 56 (2021) 4060–4062. https://doi.org/10.1002/ppul.25682.
    OpenUrl
  59. [59].
    D.W. McCormick, J.M. Bacha, N.K. El-Mallawany, C.L. Kovarik, J.S. Slone, L.R. Campbell, Disseminated cysticercosis and Kaposi sarcoma in a child with HIV/AIDS: A case report, BMC Infect. Dis. 20 (2020) 1–5. https://doi.org/10.1186/s12879-020-05039-x.
    OpenUrlCrossRefPubMed
  60. [60].
    F.R. Lyimo, A.M. Jusabani, H. Makungu, M. Mtolera, S. Surani, Thinking Outside Malaria: A Rare Case of Disseminated Cysticercosis With Cardiopulmonary Involvement From Urban Tanzania, Cureus. 13 (2021). https://doi.org/10.7759/cureus.12851.
  61. [61].
    P. Rajaonarison, S. Ralamboson, C. Andriamamonjy, R. Ramanampamonjy, R. Ce, F. Razafindratrimo, R. Villeneuve, A. Andriantsimahavandy, Diagnostic de la neurocysticercose : à propos d ’ un cas, Arch. Inst. Pasteur Madagascar. 67 (2001) 53–56. https://www.researchgate.net/publication/237675160_Diagnostic_de_la_neurocysticercose_a_propos_d’un_cas (accessed October 23, 2021).
    OpenUrlPubMed
  62. [62].
    R.A. Rakotoarivelo, R.L. Andrianasolo, D. Ranoharison, R.O.S. Rakoto, F.A. Sendrasoa, M.J. de Dieu Randria, Neurocysticercosis as an important differential of paradoxical response during antituberculosis therapy in HIV-negative patient, Asian Pacific J. Trop. Dis. 1 (2011) 333–334. https://doi.org/10.1016/S2222-1808(11)60077-7.
    OpenUrl
  63. [63].
    N. Kalata, J. Ellis, L. Benjamin, S. Kampondeni, P. Chiodini, T. Harrison, D.G. Lalloo, R.S. Heyderman, Neurological deterioration in a patient with HIV-associated cryptococcal meningitis initially improving on antifungal treatment: a case report of coincidental racemose neurocysticercosis, BMC Infect. Dis. 21 (2021) 1–5. https://doi.org/10.1186/s12879-021-06425-9.
    OpenUrlCrossRefPubMed
  64. [64].
    V. Saldanha, G. Saldanha, R.P. Reys, C.A. Benson, E.V. Noormahomed, Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia., EC Microbiol. 14 (2018) 736–740. http://www.ncbi.nlm.nih.gov/pubmed/31681909%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC6824723 (accessed July 5, 2022).
    OpenUrl
  65. [65].
    A.M. Vitali, R. Jithoo, Multiple forms of neurocysticercosis in a single patient, Br. J. Neurosurg. 18 (2004) 650–651. https://doi.org/10.1080/02688690400022847.
    OpenUrlPubMed
  66. [66].
    T. Motsepe, D. Ackerman, Spinal and vertebral neurocysticercosis in an HIV-positive female patient, South. African J. Epidemiol. Infect. 27 (2012) 133–136. https://doi.org/10.1080/10158782.2012.11441499.
    OpenUrl
  67. [67].
    K. Jivan, A. Mochan, G. Modi, Intraventricular neurocysticercosis causing acute unilateral hydrocephalus, African J. Psychiatry (South Africa). 13 (2010) 315–317. https://www.researchgate.net/publication/47460261_Intraventricular_neurocysticercosis_causing_acute_unilateral_hydrocephalus (accessed October 22, 2021).
    OpenUrl
  68. [68].
    H.F. Sibat, Neurocysticercosis, Epilepsy, COVID-19 and a Novel Hypothesis: Cases Series and Systematic Review, Clin. Schizophr. Relat. Psychoses. 15 (2021). https://doi.org/10.3371/CSRP.FH.121421.
  69. [69].
    B. Ndlovu, Combined surgical and medical treatment of racemose neurocysticercosis in Swaziland, Neuroradiology. 60 (2018) 109–110. https://www.embase.com/search/results?subaction=viewrecord&id=L621458617&from=export.
    OpenUrlCrossRefPubMed
  70. [70].
    F. Mukonde, Abstracts, Epilepsia. 55 (2014) 4–246. https://doi.org/10.1111/epi.12675.
    OpenUrl
  71. [71].
    J. Manske, C. McVey, H. Chengazi, O. Siddiqi, D. Saylor, Intramedullary spinal neurocysticercosis (P5.9-031), Neurology. 92 (2019).
  72. [72].
    A. Musara, N. Soko, S. Shamu, Suprasellar cysticercosis cyst with optic nerve compression masquerading as an arachnoid cyst, Middle East Afr. J. Ophthalmol. 26 (2019) 114–116. https://doi.org/10.4103/meajo.MEAJO_142_18.
    OpenUrl
  73. [73].
    G. Nsengiyumva, M. Druet-Cabanac, B. Ramanankandrasana, B. Bouteille, L. Nsizabira, P.M. Preux, Cysticercosis as a major risk factor for epilepsy in Burundi, East Africa, Epilepsia. 44 (2003) 950–955. https://doi.org/10.1046/j.1528-1157.2003.55302.x.
    OpenUrlCrossRefPubMedWeb of Science
  74. [74].
    P. Leutscher, A. Andriantsimahavandy, Cysticercosis in Peace Corps Volunteers in Madagascar, N. Engl. J. Med. 350 (2004) 311–312. https://doi.org/10.1056/nejm200401153500325.
    OpenUrlCrossRefPubMed
  75. [75].
    J.. Carod, J. Razafimahefa, M. Randrianarison, R.. Ramahefarisoa, M. Rakotondrazaka, M. Andriantseheno, The burden of neurocysticercosis: A multi-purpose survey in Madagascar, Clin. Microbiol. Infect. 18 (2012) 52–53. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=70822228 (accessed July 8, 2022).
    OpenUrl
  76. [76].
    J.. Carod, M. Rakotondrazaka, R.. Ramahefarisoa, D. Menard, J.. Soares, P. Dorny, P. Wilkins, Updated epidemiology of cysticercosis in Madagascar, Trop. Med. Int. Heal. 16 (2011) 270. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed10&NEWS=N&AN=70589687 (accessed July 9, 2022).
    OpenUrl
  77. [77].
    M.L. Rakotomahefa Narison, A.B.A. Ratsimbazafy, H. Randrianjafinimpanana, N. Randrianaivo, T.N. Andriatahina, H.S. Raobijaona, Aspect épidémio-clinique de la neurocysticercose dans le service de pédiatrie au CHU de Tamatave- Madagascar, Arch. Pediatr. 21 (2014) 810. https://doi.org/10.1016/S0929-693X(14)72070-6.
    OpenUrl
  78. [78].
    N.J. Zafindraibe, J. Ralalarinivo, A.I. Rakotoniaina, M.N. Maeder, M.R. Andrianarivelo, B. Contamin, A. Michault, A. Rasamindrakotroka, Séroprévalence de la cysticercose et facteurs de risque associés chez un groupe de patients vus au centre hospitalier régional de référence d’antsirabe, madagascar, Pan Afr. Med. J. 28 (2017). https://doi.org/10.11604/pamj.2017.28.260.10463.
  79. [79].
    J.F. Carod, P. Dorny, Cysticercosis in Madagascar, J. Infect. Dev. Ctries. 14 (2020) 1031–1042. https://doi.org/10.3855/JIDC.13450.
    OpenUrl
  80. [80].
    Y.A. Assane, C. Trevisan, C.M. Schutte, E.V. Noormahomed, M.V. Johansen, P. Magnussen, Neurocysticercosis in a rural population with extensive pig production in Angónia district, Tete Province, Mozambique, Acta Trop. 165 (2017) 155–160. https://doi.org/10.1016/j.actatropica.2015.10.018.
    OpenUrl
  81. [81].
    E.V. Noormahomed, N. Nhacupe, C. Mascaró-Lazcano, M.N. Mauaie, T. Buene, C.A. Funzamo, C.A. Benson, A Cross-sectional Serological Study of Cysticercosis, Schistosomiasis, Toxocariasis and Echinococcosis in HIV-1 Infected People in Beira, Mozambique, PLoS Negl. Trop. Dis. 8 (2014) e3121. https://doi.org/10.1371/journal.pntd.0003121.
  82. [82].
    R. Rottbeck, J.F. Nshimiyimana, P. Tugirimana, U.E. Düll, J. Sattler, J.C. Hategekimana, J. Hitayezu, I. Bruckmaier, M. Borchert, J.B. Gahutu, S. Dieckmann, G. Harms, F.P. Mockenhaupt, R. Ignatius, High Prevalence of Cysticercosis in People with Epilepsy in Southern Rwanda, PLoS Negl. Trop. Dis. 7 (2013). https://doi.org/10.1371/journal.pntd.0002558.
  83. [83].
    H. Foyaca-Sibat, L.D. Cowan, H. Carabin, I. Targonska, M.A. Anwary, G. Serrano- Ocaña, R.C. Krecek, A.L. Willingham, Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa, PLoS Negl. Trop. Dis. 3 (2009) e562. https://doi.org/10.1371/journal.pntd.0000562.
    OpenUrlCrossRefPubMed
  84. [84].
    A.S. Winkler, J. Blocher, H. Auer, T. Gotwald, W. Matuja, E. Schmutzhard, Epilepsy and neurocysticercosis in rural Tanzania - An imaging study, Epilepsia. 50 (2009) 987–993. https://doi.org/10.1111/j.1528-1167.2008.01867.x.
    OpenUrlCrossRefPubMed
  85. [85].
    E. Hunter, K. Burton, A. Iqbal, D. Birchall, M. Jackson, J. Rogathe, A. Jusabani, W. Gray, E. Aris, G. Kamuyu, P.P. Wilkins, C.R. Newton, R. Walker, Cysticercosis and epilepsy in rural Tanzania: A community-based case-control and imaging study, Trop. Med. Int. Heal. 20 (2015) 1171–1179. https://doi.org/10.1111/tmi.12529.
    OpenUrl
  86. [86].
    V. Schmidt, C. Kositz, K.H. Herbinger, H. Carabin, B. Ngowi, E. Naman, P.P. Wilkins, J. Noh, W. Matuja, A.S. Winkler, Association between Taenia solium infection and HIV/AIDS in northern Tanzania: A matched cross sectional-study, Infect. Dis. Poverty. 5 (2016). https://doi.org/10.1186/s40249-016-0209-7.
  87. [87].
    V. Schmidt, M.C. O’Hara, B. Ngowi, K.H. Herbinger, J. Noh, P.P. Wilkins, V. Richter, C. Kositz, W. Matuja, A.S. Winkler, Taenia solium cysticercosis and taeniasis in urban settings: Epidemiological evidence from a health-center based study among people with epilepsy in Dar es Salaam, Tanzania, PLoS Negl. Trop. Dis. 13 (2019) e0007751. https://doi.org/10.1371/journal.pntd.0007751.
    OpenUrl
  88. [88].
    J.O. Mageto, C.I. Muleke, C.R. Newton, G. Samuel, Multiple parasitic infections as risk factors of active convulsive epilepsy., Sch. J. Appl. Med. Sci. 3 (2015) 178–184. http://saspublisher.com/wp-content/uploads/2015/01/SJAMS-31C178-184.pdf.
    OpenUrl
  89. [89].
    B.J. Mwang’Onde, M.J. Chacha, G. Nkwengulila, The status and health burden of neurocysticercosis in Mbulu district, northern Tanzania, BMC Res. Notes. 11 (2018) 1–5. https://doi.org/10.1186/s13104-018-3999-9.
    OpenUrlCrossRefPubMed
  90. [90].
    G. Kamuyu, C. Bottomley, J. Mageto, B. Lowe, P.P. Wilkins, J.C. Noh, T.B. Nutman, A.K. Ngugi, R. Odhiambo, R.G. Wagner, A. Kakooza-Mwesige, S. Owusu-Agyei, K. Ae- Ngibise, H. Masanja, F.H.A. Osier, P. Odermatt, C.R. Newton, Exposure to Multiple Parasites Is Associated with the Prevalence of Active Convulsive Epilepsy in Sub-Saharan Africa, PLoS Negl. Trop. Dis. 8 (2014) e2908. https://doi.org/10.1371/journal.pntd.0002908.
    OpenUrlCrossRefPubMed
  91. [91].
    K.E. Mwape, I.K. Phiri, N. Praet, N. Speybroeck, J.B. Muma, P. Dorny, S. Gabriël, The Incidence of Human Cysticercosis in a Rural Community of Eastern Zambia, PLoS Negl. Trop. Dis. 7 (2013) e2142. https://doi.org/10.1371/journal.pntd.0002142.
    OpenUrl
  92. [92].
    J.J.J. Kumwenda, G. Mateyu, S. Kampondeni, A.P. Van Dam, L. Van Lieshout, E.E.E. Zijlstra, A. van Dam, L. van Lieshout, E.E.E. Zijlstra, Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi, Stroke. 17 (2005) 960–964. https://doi.org/10.1161/01.STR.0000162585.97216.ef.
    OpenUrl
  93. [93].
    I.L. Segamwenge, N.P. Kioko, C. Mukulu, O. Jacob, W. Humphrey, J. Augustinus, Neurocysticercosis among patients with first time seizure in Northern Namibia, Pan Afr. Med. J. 24 (2016). https://doi.org/10.11604/pamj.2016.24.127.8908.
  94. [94].
    S.H. Mabaso, D. Bhana-Nathoo, S. Lucas, An audit of CT brain findings in adults with new-onset seizures in a resource restricted setting in South Africa, South African J. Radiol. 26 (2022) 7. https://doi.org/10.4102/SAJR.V26I1.2294.
    OpenUrl
  95. [95].
    J.C. Sousa-Figueiredo, D. Gamboa, J.M. Pedro, C. Fançony, A.J. Langa, R.J.S. Magalhães, J.R. Stothard, S.V. Nery, Epidemiology of malaria, schistosomiasis, geohelminths, anemia and malnutrition in the context of a demographic surveillance system in northern Angola, PLoS One. 7 (2012) e33189. https://doi.org/10.1371/journal.pone.0033189.
    OpenUrlCrossRefPubMed
  96. [96].
    D. Oliveira, F.S. Ferreira, J. Atouguia, F. Fortes, A. Guerra, S. Centeno-Lima, Infection by intestinal parasites, stunting and anemia in school-aged children from southern Angola, PLoS One. 10 (2015) e0137327. https://doi.org/10.1371/journal.pone.0137327.
    OpenUrlCrossRefPubMed
  97. [97].
    S.T. Mariam, B. Roma, S. Sorsa, S. Worku, L. Erosie, Assessment of sanitary and hygienic status of catering establishments of Awassa Town, Ethiop. J. Heal. Dev. 14 (2000). https://doi.org/10.4314/ejhd.v14i1.9934.
  98. [98].
    M. Awole, S. Gebre-Selassie, T. Kassa, G. Kibru, Prevalence of intestinal parasites in HIV-infected adult patients in Southwestern Ethiopia, Ethiop. J. Heal. Dev. 17 (2003). https://doi.org/10.4314/ejhd.v17i1.9783.
  99. [99].
    Z. Mekonnen, S. Suleman, A. Biruksew, T. Tefera, L. Chelkeba, Intestinal polyparasitism with special emphasis to soil-transmitted helminths among residents around Gilgel Gibe Dam, Southwest Ethiopia: a community based survey, BMC Public Health. 16 (2016) 1–7. https://doi.org/10.1186/s12889-016-3859-2.
    OpenUrlCrossRefPubMed
  100. [100].
    A. Alemu, Y. Shiferaw, G. Getnet, A. Yalew, Z. Addis, Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, North West Ethiopia, Asian Pac. J. Trop. Med. 4 (2011) 661–665. https://doi.org/10.1016/S1995-7645(11)60168-5.
    OpenUrlCrossRefPubMed
  101. [101].
    T. Wegayehu, T. Tsalla, B. Seifu, T. Teklu, Prevalence of intestinal parasitic infections among highland and lowland dwellers in Gamo area, South Ethiopia, BMC Public Health. 13 (2013) 1–7. https://doi.org/10.1186/1471-2458-13-151.
    OpenUrlCrossRefPubMed
  102. [102].
    M. Alamir, W. Awoke, A. Feleke, Intestinal parasites infection and associated factors among school children in Dagi primary school, Amhara National Regional State, Ethiopia, Health (Irvine. Calif). 05 (2013) 1697–1701. https://doi.org/10.4236/health.2013.510228.
    OpenUrl
  103. [103].
    S. Fekadu, K. Taye, W. Teshome, S. Asnake, Prevalence of parasitic infections in HIV- positive patients in southern Ethiopia: A cross-sectional study, J. Infect. Dev. Ctries. 7 (2013) 868–872. https://doi.org/10.3855/jidc.2906.
    OpenUrl
  104. [104].
    B. Abera, G. Alem, M. Yimer, Z. Herrador, Epidemiology of soil-transmitted helminths, Schistosoma mansoni, and haematocrit values among schoolchildren in Ethiopia, J. Infect. Dev. Ctries. 7 (2013) 253–260. https://doi.org/10.3855/jidc.2539.
    OpenUrlCrossRefPubMed
  105. [105].
    H. Mamo, Intestinal parasitic infections among prison inmates and tobacco farm workers in Shewa Robit, north-central Ethiopia, PLoS One. 9 (2014) e99559. https://doi.org/10.1371/journal.pone.0099559.
    OpenUrl
  106. [106].
    L. Worku, D. Damte, M. Endris, H. Tesfa, M. Aemero, Schistosoma mansoni infection and associated determinant factors among school children in Sanja Town, northwest Ethiopia, J. Parasitol. Res. 2014 (2014). https://doi.org/10.1155/2014/792536.
  107. [107].
    M. Alemayehu, W. Birhan, Y. Belyhun, M. Sahle, B. Tessema, Prevalence of smear positive tuberculosis, intestinal parasites and their co-infection among tuberculosis suspects in Gondar University Hospital and Gondar Poly Clinic, North West Ethiopia, J. Microb. Biochem. Technol. 6 (2014) 179–184. https://doi.org/10.4172/1948-5948.1000140.
    OpenUrl
  108. [108].
    M. Desta, D. Asrat, W. Yimtubezinash, N. Demiss, Prevalence of intestinal parasites and Salmonella and Shigella among food handlers at food service establishments in the main campus and Health Sciences College of Hawassa University, Hawassa, Ethiopia, Ethiop. J. Heal. Dev. 28 (2014) 29–34. http://www.etpha.org/publications/the-ethiopian-journal-of-health-development.html%0Ahttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=cagh&AN=20153041959%0Ahttp://wa4py6yj8t.search.serialssolutions.com/?url_ver=Z39.88-2004&rft_val_fmt= (accessed October 18, 2021).
    OpenUrl
  109. [109].
    G. Beyene, H. Tasew, Prevalence of intestinal parasite, Shigella and Salmonella species among diarrheal children in Jimma health center, Jimma southwest Ethiopia: A cross sectional study, Ann. Clin. Microbiol. Antimicrob. 13 (2014) 10. https://doi.org/10.1186/1476-0711-13-10.
    OpenUrl
  110. [110].
    A. Abossie, M. Seid, Assessment of the prevalence of intestinal parasitosis and associated risk factors among primary school children in Chencha town, Southern Ethiopia, BMC Public Health. 14 (2014). https://doi.org/10.1186/1471-2458-14-166.
  111. [111].
    A. Gebreyesus, K. Adane, L. Negash, T. Asmelash, S. Belay, M. Alemu, M. Saravanan, Prevalence of Salmonella typhi and intestinal parasites among food handlers in Mekelle University student cafeteria, Mekelle, Ethiopia, Food Control. 44 (2014) 45–48. https://doi.org/10.1016/j.foodcont.2014.03.040.
    OpenUrl
  112. [112].
    J.M. Ramos, N. Rodríguez-Valero, G. Tisiano, H. Fano, T. Yohannes, A. Gosa, E. Fruttero, F. Reyes, M. Górgolas, Different profile of intestinal protozoa and helminthic infections among patients with diarrhoea according to age attending a rural hospital in southern Ethiopia, Trop. Biomed. 31 (2014) 392–397. https://pubmed.ncbi.nlm.nih.gov/25134911/ (accessed October 27, 2021).
    OpenUrl
  113. [113].
    M.B. Shiferaw, A.D. Mengistu, Helminthiasis: Hookworm infection remains a public health problem in Dera District, South Gondar, Ethiopia, PLoS One. 10 (2015) e0144588. https://doi.org/10.1371/journal.pone.0144588.
    OpenUrl
  114. [114].
    A. Bereket, T. Zewdneh, Prevalence of intestinal helminthiasis and associated risk factors among schoolchildren in Dawro Zone, Southern Ethiopia, J. Biol. Agric. Healthc. 5 (2015) 76–82. https://www.iiste.org/Journals/index.php/JBAH/article/view/23238 (accessed October 27, 2021).
    OpenUrl
  115. [115].
    G. Tigist, E. Fantahun, E. Hailu, H. Kibe, O. Fesseha, W. Godana, W.G. Tsadik, Prevalence of Intestinal Parasitosis Among HIV / AIDS Patients Attending ART Clinic of Arbaminch Hospital., Researchgate.Net. (2015) 1–6. https://www.researchgate.net/profile/Wanzahun-Godana/publication/283351146_PREVALENCE_OF_INTESTINAL_PARASITOSIS_AMONG_HIVAIDS_PATIENTS_ATTENDING_ART_CLINIC_OF_ARBAMINCH_HOSPITAL/links/5636572908aeb786b703f0ae/PREVALENCE-OF-INTESTINAL-PARASITOSIS-AMONG-HIV (accessed October 22, 2021).
  116. [116].
    M. Mama, G. Alemu, Prevalence and factors associated with intestinal parasitic infections among food handlers of Southern Ethiopia: Cross sectional study Infectious Disease epidemiology, BMC Public Health. 16 (2016) 1–7. https://doi.org/10.1186/s12889-016-2790-x.
    OpenUrlCrossRefPubMed
  117. [117].
    A. Alemu, Y. Tegegne, D. Damte, M. Melku, Schistosoma mansoni and soil-transmitted helminths among preschool-aged children in Chuahit, Dembia district, Northwest Ethiopia: Prevalence, intensity of infection and associated risk factors, BMC Public Health. 16 (2016). https://doi.org/10.1186/s12889-016-2864-9.
  118. [118].
    A. Arota Amado, F. Wadilo Wada, F. Solomon Bisetegn, Y. Abreham Leka, Non- opportunistic intestinal parasitic infections among HIV-infected individuals at Wolaita Sodo Hospital, South Ethiopia, J. Coast. Life Med. 4 (2016) 353–357. https://doi.org/10.12980/jclm.4.2016j6-57.
    OpenUrl
  119. [119].
    B. Alemayehu, Z. Tomass, F. Wadilo, D. Leja, S. Liang, B. Erko, Epidemiology of intestinal helminthiasis among school children with emphasis on Schistosoma mansoni infection in Wolaita zone, Southern Ethiopia, BMC Public Health. 17 (2017). https://doi.org/10.1186/s12889-017-4499-x.
  120. [120].
    H. Girma, G. Beyene, Z. Mekonnen, Prevalence of intestinal parasites among food handlers at cafeteria of Jimma University Specialized Hospital, Southwest Ethiopia, Asian Pacific J. Trop. Dis. 7 (2017) 467–471. https://doi.org/10.12980/apjtd.7.2017D7-20.
    OpenUrl
  121. [121].
    M. Alemu, B. Kinfe, D. Tadesse, W. Mulu, T. Hailu, E. Yizengaw, Intestinal parasitosis and anaemia among patients in a Health Center, North Ethiopia, BMC Res. Notes. 10 (2017) 1–7. https://doi.org/10.1186/s13104-017-2957-2.
    OpenUrlCrossRef
  122. [122].
    D.G. Feleke, S. Arega, M. Tekleweini, K. Kindie, A. Gedefie, Schistosoma mansoni and other helminthes infections at Haike primary school children, North-East, Ethiopia: A cross-sectional study, BMC Res. Notes. 10 (2017) 1–6. https://doi.org/10.1186/s13104-017-2942-9.
    OpenUrlCrossRef
  123. [123].
    Y. Tegegne, T. Wondmagegn, L. Worku, A. Jejaw Zeleke, Prevalence of Intestinal Parasites and Associated Factors among Pulmonary Tuberculosis Suspected Patients Attending University of Gondar Hospital, Gondar, Northwest Ethiopia, J. Parasitol. Res. 2018 (2018). https://doi.org/10.1155/2018/9372145.
  124. [124].
    G. Alemu, M. Mama, Intestinal helminth co-infection and associated factors among tuberculosis patients in Arba Minch, Ethiopia, BMC Infect. Dis. 17 (2017) 1–9. https://doi.org/10.1186/s12879-017-2195-1.
    OpenUrlCrossRefPubMed
  125. [125].
    T. Asmare, W. Awoke, G. Alem, Prevalence of Intestinal Parasites and Associated Factors among AdultPre-ART and ART Patients in Goncha Siso Enesie Woreda, East Gojjam,Northwest Ethiopia, 2014, J. AIDS Clin. Res. 8 (2017). https://doi.org/10.4172/2155-6113.1000734.
  126. [126].
    D. Teklemariam, M. Legesse, A. Degarege, S. Liang, B. Erko, Schistosoma mansoni and other intestinal parasitic infections in schoolchildren and vervet monkeys in Lake Ziway area, Ethiopia, BMC Res. Notes. 11 (2018) 1–6. https://doi.org/10.1186/s13104-018-3248-2.
    OpenUrlCrossRefPubMed
  127. [127].
    T. Zemene, M.B. Shiferaw, Prevalence of intestinal parasitic infections in children under the age of 5 years attending the Debre Birhan referral hospital, North Shoa, Ethiopia, BMC Res. Notes. 11 (2018) 1–6. https://doi.org/10.1186/s13104-018-3166-3.
    OpenUrlCrossRefPubMed
  128. [128].
    G. Alemu, Z. Aschalew, E. Zerihun, Burden of intestinal helminths and associated factors three years after initiation of mass drug administration in Arbaminch Zuria district, Southern Ethiopia, BMC Infect. Dis. 18 (2018). https://doi.org/10.1186/s12879-018-3330-3.
  129. [129].
    M. Alemu, A. Anley, K. Tedla, Magnitude of Intestinal Parasitosis and Associated Factors in Rural School Children, Northwest Ethiopia, Ethiop. J. Health Sci. 29 (2019) 923–928. https://doi.org/10.4314/ejhs.v29i1.14.
    OpenUrl
  130. [130].
    B. Sitotaw, H. Mekuriaw, D. Damtie, Prevalence of intestinal parasitic infections and associated risk factors among Jawi primary school children, Jawi town, north-west Ethiopia, BMC Infect. Dis. 19 (2019). https://doi.org/10.1186/s12879-019-3971-x.
  131. [131].
    E. Kebede, A. Seid, S. Akele, Prevalence and associated risk factors of intestinal parasitic infections among asymptomatic food handlers in Wollo University student’s cafeteria, Northeastern Ethiopia, BMC Res. Notes. 12 (2019) 1–6. https://doi.org/10.1186/s13104-019-4182-7.
    OpenUrlCrossRef
  132. [132].
    T. Eyamo, M. Girma, T. Alemayehu, Z. Bedewi, Soil-Transmitted Helminths And Other Intestinal Parasites Among Schoolchildren In Southern Ethiopia, Res. Rep. Trop. Med. Volume 10 (2019) 137–143. https://doi.org/10.2147/rrtm.s210200.
    OpenUrl
  133. [133].
    N. Mohamed, A. Muse, M. Wordofa, D. Abera, A. Mesfin, M. Wolde, K. Desta, A. Tsegaye, B. Taye, Increased prevalence of cestode infection associated with history of deworming among primary school children in Ethiopia, Am. J. Trop. Med. Hyg. 101 (2019) 641–649. https://doi.org/10.4269/ajtmh.19-0284.
    OpenUrl
  134. [134].
    A.A. Obala, C.J. Simiyu, D.O. Odhiambo, V. Nanyu, P. Chege, R. Downing, E. Mwaliko, A.W. Mwangi, D. Menya, D. Chelagat, H.D.N. Nyamogoba, P.O. Ayuo, W.P. O’Meara, M. Twagirumukiza, D. Vandenbroek, B.B.O. Otsyula, J. De Maeseneer, Webuye health and demographic surveillance systems baseline survey of soil-transmitted helminths and intestinal protozoa among children up to five years, J. Trop. Med. 2013 (2013). https://doi.org/10.1155/2013/734562.
  135. [135].
    B.N. Lowoko, B. Ngugi, A. Malai, J.K. Mutai, Factors associated with intestinal parasites among school going children in Lodwar Municipality, Turkana County, Kenya, East Afr. Med. J. 94 (2018) 649–663. https://doi.org/10.4314/eamj.v94i8.
    OpenUrl
  136. [136].
    T.P.W. Jones, J.D. Hart, K. Kalua, R.L. Bailey, A prevalence survey of enteral parasites in preschool children in the Mangochi District of Malawi, BMC Infect. Dis. 19 (2019). https://doi.org/10.1186/s12879-019-4439-8.
  137. [137].
    E. V. Noormahomed, J.G. Pividal, S. Azzouz, C. Mascaró, M. Delgado-Rodríguez, A. Osuna, Seroprevalence of anti-cysticercus antibodies among the children living in the urban environs of Maputo, Mozambique, Ann. Trop. Med. Parasitol. 97 (2003) 31–35. https://doi.org/10.1179/000349803125002742.
    OpenUrlPubMed
  138. [138].
    G. Augusto, R. Nalá, V. Casmo, A. Sabonete, L. Mapaco, J. Monteiro, Geographic distribution and prevalence of schistosomiasis and soil-transmitted helminths among schoolchildren in mozambique, Am. J. Trop. Med. Hyg. 81 (2009) 799–803. https://doi.org/10.4269/ajtmh.2009.08-0344.
    OpenUrlAbstract/FREE Full Text
  139. [139].
    A.R.P. Walker, L.A. Dini, B.F. Walker, J.A. Frean, Helminthiasis in African children in a relatively low risk region in south Africa: implications for treatment?, S Afr J Epidemiol Infect South. 15 (2000). https://www.cabdirect.org/cabdirect/abstract/20013078709 (accessed October 22, 2021).
  140. [140].
    H. Sacolo-Gwebu, M. Chimbari, C. Kalinda, Prevalence and risk factors of schistosomiasis and soil-transmitted helminthiases among preschool aged children (1-5 years) in rural KwaZulu-Natal, South Africa: A cross-sectional study, Infect. Dis. Poverty. 8 (2019) 1–12. https://doi.org/10.1186/s40249-019-0561-5.
    OpenUrl
  141. [141].
    U.C. Braae, P. Magnussen, W. Harrison, B. Ndawi, F. Lekule, M.V. Johansen, Effect of National Schistosomiasis Control Programme on Taenia solium taeniosis and porcine cysticercosis in rural communities of Tanzania, Parasite Epidemiol. Control. 1 (2016) 245–251. https://doi.org/10.1016/j.parepi.2016.08.004.
    OpenUrl
  142. [142].
    E. Buzigi, Prevalence of Intestinal Parasites , and its Association with Severe Acute Malnutrition Related Diarrhoea, J. Biol. Agric. Healthc. 5 (2015). https://www.researchgate.net/publication/271763982_Prevalence_of_Intestinal_Parasites_and_its_Association_with_Severe_Acute_Malnutrition_Related_Diarrhoea (accessed October 18, 2021).
  143. [143].
    S. Fuhrimann, M.S. Winkler, N.B. Kabatereine, E.M. Tukahebwa, A.A. Halage, E. Rutebemberwa, K. Medlicott, C. Schindler, J. Utzinger, G. Cissé, Risk of Intestinal Parasitic Infections in People with Different Exposures to Wastewater and Fecal Sludge in Kampala, Uganda: A Cross-Sectional Study, PLoS Negl. Trop. Dis. 10 (2016) e0004469. https://doi.org/10.1371/journal.pntd.0004469.
    OpenUrl
  144. [144].
    P. Oboth, Y. Gavamukulya, B.J. Barugahare, Prevalence and clinical outcomes of Plasmodium falciparum and intestinal parasitic infections among children in Kiryandongo refugee camp, mid-Western Uganda: A cross sectional study, BMC Infect. Dis. 19 (2019) 1–8. https://doi.org/10.1186/s12879-019-3939-x.
    OpenUrlCrossRef
  145. [145].
    K. Modjarrad, I. Zulu, D.T. Redden, L. Njobvu, D.O. Freedman, S.H. Vermund, Prevalence and predictors of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting, Am. J. Trop. Med. Hyg. 73 (2005) 777–782. https://doi.org/10.4269/ajtmh.2005.73.777.
    OpenUrlAbstract/FREE Full Text
  146. [146].
    J. Siwila, I.G.K. Phiri, H.L. Enemark, M. Nchito, A. Olsen, Intestinal helminths and protozoa in children in pre-schools in Kafue district, Zambia, Trans. R. Soc. Trop. Med. Hyg. 104 (2010) 122–128. https://doi.org/10.1016/j.trstmh.2009.07.024.
    OpenUrlCrossRefPubMed
Back to top
Posted December 22, 2022.
Download PDF

Supplementary Material

Data/Code
Email
The epidemiology of human Taenia solium infections: a systematic review of the distribution in Eastern and Southern Africa
Gideon Zulu, Dominik Stelzle, Kabemba E. Mwape, Tamara M. Welte, Hilde Strømme, Chishimba Mubanga, Wilbroad Mutale, Annette Abraham, Alex Hachangu, Veronika Schmidt, Chummy. S. Sikasunge, Isaac. K. Phiri, Andrea S. Winkler
medRxiv 2022.12.21.22283765; doi: https://doi.org/10.1101/2022.12.21.22283765
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area